Sharp HealthCare
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Sharp HealthCare sits in the top decile of US sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count).
Sharp HealthCare: 32 sponsored US clinical trials, 1 recruiting.
Sharp HealthCare sponsors 32 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 26 completed. 6 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Extreme Prematurity, with 2 trials.
Top-decile sponsor footprint
Sharp HealthCare ranks in the top decile of sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
26 of 28 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
32 total, page 1 of 1
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
NCT07301385
Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants
NCT04413097
Rapid Diagnostics for Genetic Disorders in Neonates
NCT07005700
NICU Antibiotics and Outcomes (NANO) Follow-up Study
NCT05977400
Sharp Health Companion App for Cataract Surgery Preparation and Recovery
NCT07028359
Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants
NCT04848727
Time to Accurate Heart Rate on Neonatal Outcomes
NCT04587934
Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation
NCT04494867
Safety of Manganese Restriction in Neonatal Parenteral Nutrition
NCT04259008
Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
NCT04340557
Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants
NCT04209946
Comparison of Trigger Finger Orthotic Wearing Schedules
NCT04094389
Physiological Changes With High-Flow Nasal Cannula
NCT03700606
Echocardiography Sub-Study of the Umbilical Cord Milking in Non-Vigorous Infants Trial (MINVI)
NCT03798093
Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)
NCT03621943
Cardiac and Cerebral Hemodynamics With Umbilical Cord Milking Compared With Early Cord Clamping
NCT03621956
Umbilical Cord Milking in Non-Vigorous Infants
NCT03631940
Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2
NCT03019367
IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
NCT02660346
3D Imaging of Neonatal Faces
NCT02603796
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
NCT02605733
Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury
NCT02445417
Novel Epidermal Recording and Detection of Seizures
NCT02451618
Neonatal Resuscitation With Intact Cord
NCT02231411
Changes in Cardiac Output During Delayed Umbilical Cord Clamping
NCT02195037
Validation of Fore-Sight Cerebral & Tissue Oximeter Saturation Measurements on Neonates ≤ 5 kg
NCT02017652
Early Versus Routine Caffeine Administration in Extremely Preterm Neonates
NCT01783561
Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants
NCT01773746
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
NCT01866982
Prophylactic Ephedrine and Combined Spinal Epidurals for Labor
NCT02062801
Effects of Milking the Umbilical Cord on Systemic Blood Flow
NCT01434732
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
NCT01540994
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 5 |
Where Sharp HealthCare enrollment is open (later-stage tilt)
1 recruiting of 32 indexed (3% open); 26 completed (81%).
Phase mix: 6 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Extreme Prematurity (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Sharp HealthCare: open-pipeline peers nationwide
Peers matched on 32 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Sharp HealthCare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 32 trials (± recruiting share)
- Aerie Pharmaceuticals · 32 trials · 0% recruiting
- Allina Health System · 32 trials · 3% recruiting
- Ardea Biosciences · 32 trials · 0% recruiting
- Hebrew SeniorLife · 32 trials · 19% recruiting
Sponsors near 3% open enrollment (± trial volume)
- CooperVision · 3% recruiting · 64 trials
- Masimo Corporation · 3% recruiting · 96 trials
- MiMedx Group · 3% recruiting · 32 trials
- Aclaris Therapeutics · 3% recruiting · 33 trials
Related
What to do with this Sharp HealthCare page
32 registered trials is a research-attention snapshot, not an endorsement of Sharp HealthCare or any single study.
- 1 of Sharp HealthCare's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Extreme Prematurity is the condition Sharp HealthCare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Extreme Prematurity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Sharp HealthCare pipeline card: 32 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.